Cargando…

POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients

Detalles Bibliográficos
Autores principales:	Mozaffari, E, Liang, S, Stewart, HM, Thrun, M, Hodgkins, P, Haubrich, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769641/ http://dx.doi.org/10.1016/j.jval.2021.11.123

Ejemplares similares

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19
por: Mozaffari, E, et al.
Publicado: (2022)

Independent Predictors and Causes of Thirty-Day Gastrointestinal Readmissions Following COVID-19-Related Hospitalizations: Analysis of the National Readmission Database
por: Kwei-Nsoro, Robert, et al.
Publicado: (2023)

PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study
por: Mozaffari, E., et al.
Publicado: (2021)

Thirty‐day readmission after spontaneous intracerebral hemorrhage
por: Bjerkreim, Anna Therese, et al.
Publicado: (2018)

38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality
por: Mozaffari, Essy, et al.
Publicado: (2021)

Thirty-Day readmissions among COVID-19 patients hospitalized during the early pandemic in the United States: Insights from the Nationwide Readmissions Database
por: Muzammil, Taimur Sohail, et al.
Publicado: (2023)

POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19
por: Jhamb, S, et al.
Publicado: (2022)

The number of discharge medications predicts thirty-day hospital readmission: a cohort study
por: Picker, David, et al.
Publicado: (2015)

Thirty‐Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database
por: Morita, Yusuke, et al.
Publicado: (2019)

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
por: Mozaffari, Essy, et al.
Publicado: (2021)

POSB193 COVID-19 Vaccine Development Pipeline: 2021
por: Ahlawat, R, et al.
Publicado: (2022)

Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope
por: Siddappa Malleshappa, Sudeep K., et al.
Publicado: (2020)

POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries
por: Davis-Ajami, ML, et al.
Publicado: (2022)

Thirty-Day Readmission Rates in Orthopedics: A Systematic Review and Meta-Analysis
por: Bernatz, James T., et al.
Publicado: (2015)

Thirty-day Complications and Readmission Rates in Elderly Patients After Shoulder Arthroplasty
por: Koh, Justin, et al.
Publicado: (2018)

Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis
por: Kichloo, Asim, et al.
Publicado: (2022)

Factors Influencing Thirty-Day Readmission Rate in Patients With Heart Failure Exacerbation
por: Alsamman, Mrhaf, et al.
Publicado: (2022)

Thirty-Day Hospital Readmissions: A Predictor of Higher All-cause Mortality for Up to Two Years
por: Shaw, Jawaid A, et al.
Publicado: (2020)

Thirty‐day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation
por: Tennison, Jegy M., et al.
Publicado: (2021)

Perioperative Stroke and Thirty-Day Hospital Readmission After Cardiac Surgeries: State Inpatient Database Study
por: Alrifai, Nada, et al.
Publicado: (2022)

POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies
por: Net, P, et al.
Publicado: (2022)

POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19.
por: Santos, A, et al.
Publicado: (2022)

POSB103 COVID-19 Positive Patients Hospital Management in the Italian Setting: The Economic Impact
por: Ferrario, LB, et al.
Publicado: (2022)

Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
por: Jang, Sun-Joo, et al.
Publicado: (2021)

Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database
por: Jha, Anil Kumar, et al.
Publicado: (2022)

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
por: Prabhu, Vimalanand S, et al.
Publicado: (2017)

Thirty-day hospital readmission prediction model based on common data model with weather and air quality data
por: Ryu, Borim, et al.
Publicado: (2021)

Correction to: Perioperative Stroke and Thirty-Day Hospital Readmission After Cardiac Surgeries: State Inpatient Database Study
por: Alrifai, Nada, et al.
Publicado: (2022)

POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated?
por: Vives, A, et al.
Publicado: (2022)

Cannabis Use and Its Association With Thirty- and Ninety-Day Hospital Readmissions for Patients Admitted for an Inflammatory Bowel Disease Exacerbation
por: Oseni, Ellen A., et al.
Publicado: (2023)

Thirty-day readmission rates and associated risk factors after coronary artery bypass grafting
por: Alghafees, Mohammad A., et al.
Publicado: (2020)

Thirty‐Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population‐Based Data
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2020)

POSB396 Identification of Risk Factors Associated with ICU Admission in COVID-19 Patients
por: Kukreja, I, et al.
Publicado: (2022)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program
por: Huckfeldt, Peter, et al.
Publicado: (2019)

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices
por: Buhr, Russell G., et al.
Publicado: (2019)

Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis
por: Mumtaz, Khalid, et al.
Publicado: (2020)

Thirty-Day Unplanned Readmission After Ambulatory Laparoscopic Cholecystectomy in Western China: A Retrospective Study
por: MingJun, Huang, et al.
Publicado: (2021)

Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma
por: Dahiya, Dushyant Singh, et al.
Publicado: (2022)

Outcomes of Thirty-Day Readmission in Patients With Heart Failure on Index Hospitalization Undergoing Transcatheter Edge-to-Edge Mitral Repair: Insights from the United States Nationwide Readmission Database
por: Zahid, Salman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d9s2rm0k1kk0d5q0pm9k0ceemh